PF-06823859
Pfizer
['derm']
#eular2023 #pos1207 promising therapy for dermatomyositis. data from stage one of phase 2 rct (n=18) showed anti-ifn beta mab improved clinical, pros, extra-muscular activity and reduced ck levels vs placebo. no cases of hzv. one to watch out in the next few years 
Rheumatologist. Interested in B-cells, Lupus, Sjogren, Pre-Connective Tissue Disease, Tennis, Running & Travelling 🌏